Australian Clinical Labs Ltd
ASX:ACL
Australian Clinical Labs Ltd
ASX:ACL
Price:
2.44 AUD
1.24%
Market Closed
Updated:
May 4, 2024
Australian Clinical Labs Ltd
Cash from Investing Activities
|
Australian Clinical Labs Ltd
Cash from Investing Activities Peer Comparison
Comparables:
HLA
SHL
IDX
CAJ
H
HLS
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Cash from Investing Activities
-AU$72m
|
CAGR 3-Years
-75%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
|
Healthia Ltd
ASX:HLA
|
Cash from Investing Activities
-AU$28.6m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Cash from Investing Activities
-AU$1.5B
|
CAGR 3-Years
-67%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-15%
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Cash from Investing Activities
-AU$46.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Capitol Health Ltd
ASX:CAJ
|
Cash from Investing Activities
-AU$21.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
19%
|
CAGR 10-Years
-7%
|
|
H
|
Healius Ltd
ASX:HLS
|
Cash from Investing Activities
AU$53.6m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Australian Clinical Labs Ltd's Cash from Investing Activities?
Cash from Investing Activities
-72m
AUD
-72m
AUD
Based on the financial report for Jun 30, 2022, Australian Clinical Labs Ltd's Cash from Investing Activities amounts to -72m AUD.
What is Australian Clinical Labs Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-43%
-43%
Over the last year, the Cash from Investing Activities growth was -1 086%. The average annual Cash from Investing Activities growth rates for Australian Clinical Labs Ltd have been -75% over the past three years , -43% over the past five years .
You don't have any saved screeners yet
